Both in Pharmaceuticals
Trevi Therapeutics vs Sarepta Therapeutics,
Over the past year TRVI returned +27.1% and SRPT returned −19.0%; their daily moves had a correlation of 0.23.
TRVI +27.1% SRPT −19.0%Growth of $1, one year, split-adjusted
| Metric | TRVI | SRPT |
|---|---|---|
| Price | $13.35 | $19.04 |
| Market cap | $1.90B | $2.01B |
| Today | 0.00% | +0.79% |
| 1 month | −7.4% | +2.1% |
| 6 months | −3.4% | −7.9% |
| Year to date | +6.6% | −11.5% |
| 1 year | +27.1% | −19.0% |
| Revenue growth (YoY) | — | −34.3% |
| Gross margin | — | 62.8% |
| Net margin | — | −1.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.0× |
| Net cash | $318.9M | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | 39.0% | 63.2% |
| Short % of float | 14.4% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).